Back to top

Myriad Genetics: (MYGN)

(Delayed quote from NSDQ) As of Aug 28, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$36.01 USD

36.01

+0.23 (0.64%)

Volume: 523,904

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Income Statements

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Sales 778 613 496 402 363
Cost Of Goods 109 80 65 47 44
Gross Profit 669 534 431 355 318
Selling & Adminstrative & Depr. & Amort Expenses 395 306 251 198 183
Income After Depreciation & Amortization 274 228 180 158 135
Non-Operating Income 3 5 4 2 6
Interest Expense 0 0 0 0 0
Pretax Income 278 233 185 160 141
Income Taxes 102 86 72 59 -11
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 176 147 112 101 152
Extras & Discontinued Operations 0 0 0 0 0
Net Income 176 147 112 101 152
Depreciation Footnote 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Income Before Depreciation & Amortization 288 237 189 165 142
Depreciation & Amortization (Cash Flow) 14 9 9 7 7
Income After Depreciation & Amortization 274 228 180 158 135
Earnings Per Share Data 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Average Shares 78.18 83.33 86.47 91.70 99.15
Diluted EPS Before Non-Recurring Items 2.43 1.77 1.30 1.10 1.39
Diluted Net EPS 2.25 1.77 1.30 1.10 1.54

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Sales 188.77 182.92 204.06 202.47 174.12
Cost Of Goods 30.98 26.61 26.13 25.48 22.07
Gross Profit 157.79 156.32 177.93 176.99 152.04
SG&A, R&D, and Dept/Amort Expenses 104.54 101.03 94.93 94.08 86.13
Income After SG&A, R&D, and Dept/Amort Expenses 53.25 55.29 83.00 82.91 65.91
Non-Operating Income -0.70 2.06 1.15 0.92 1.31
Interest Expense 0.00 0.00 0.00 0.00 0.00
Pretax Income 52.55 57.34 84.14 83.83 67.23
Income Taxes 18.92 20.57 33.78 28.36 23.15
Minority Interest 0.00 0.00 0.00 0.00 0.00
Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
Other Income/Charges 0.00 0.00 0.00 0.00 0.00
Income From Cont. Operations 33.63 36.77 50.36 55.47 44.08
Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Net Income 33.63 36.77 50.36 55.47 44.08
Earnings Per Share Data 6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Average Shares 77.68 76.37 76.83 81.80 82.64
Diluted EPS Before Non-Recurring Items 0.48 0.60 0.66 0.68 0.53
Diluted Net EPS 0.43 0.48 0.66 0.68 0.53
 

MYGN Chart by YCharts